These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35499710)

  • 61. DNA methylation analysis of the SDC2, SEPT9 and VIM genes in fecal DNA for colorectal cancer diagnosis.
    Liu Y; Ming H; Xu L; Li L; Liu Q; Zhao J; Zhong C; Li H
    BMC Cancer; 2024 Sep; 24(1):1205. PubMed ID: 39350171
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis.
    Yuan Y; Qu B; Yan J; Wang H; Yin L; Han Q
    Panminerva Med; 2015 Jun; 57(2):55-64. PubMed ID: 25256821
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The clinical value of multi-target stool fecal immunochemical test-DNA in early screening and diagnosis for colorectal cancer].
    Li YL; Guan X; Dou LZ; Liu Y; Huang HY; Huang SK; Yang ZX; Wei BJ; Wu Y; Chen ZH; Wang GQ; Wang X; Cui W
    Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(33):2607-2613. PubMed ID: 36058686
    [No Abstract]   [Full Text] [Related]  

  • 64. The methylation of SDC2 and TFPI2 defined three methylator phenotypes of colorectal cancer.
    Lei R; Zhao Y; Huang K; Wang Q; Wan K; Li T; Yang H; Lv X
    BMC Gastroenterol; 2022 Feb; 22(1):88. PubMed ID: 35227195
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Application Value of Syndecan-2 Gene Methylation for Colorectal Cancer Diagnosis: A Clinical Study and Meta-Analyses.
    Yue C; Zhang Y; Wang Y; Zhang Z; Zhang M; Wang H; Chen W; Shang Z; Xin Y; Zhang X; Zhang Y
    Front Med (Lausanne); 2022; 9():753545. PubMed ID: 35372441
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer.
    Zhang W; Yang C; Wang S; Xiang Z; Dou R; Lin Z; Zheng J; Xiong B
    Cancer Manag Res; 2021; 13():3601-3617. PubMed ID: 33958894
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
    Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA
    Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer.
    Oh T; Kim N; Moon Y; Kim MS; Hoehn BD; Park CH; Kim TS; Kim NK; Chung HC; An S
    J Mol Diagn; 2013 Jul; 15(4):498-507. PubMed ID: 23747112
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study.
    Palomba G; Doneddu V; Cossu A; Paliogiannis P; Manca A; Casula M; Colombino M; Lanzillo A; Defraia E; Pazzola A; Sanna G; Putzu C; Ortu S; Scartozzi M; Ionta MT; Baldino G; Sarobba G; Capelli F; Sedda T; Virdis L; Barca M; Gramignano G; Budroni M; Tanda F; Palmieri G
    J Transl Med; 2016 Oct; 14(1):292. PubMed ID: 27737711
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Longitudinal molecular characterization of endoscopic specimens from colorectal lesions.
    Minarikova P; Benesova L; Halkova T; Belsanova B; Suchanek S; Cyrany J; Tuckova I; Bures J; Zavoral M; Minarik M
    World J Gastroenterol; 2016 May; 22(20):4936-45. PubMed ID: 27239120
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms.
    Zeng T; Huang Z; Yu X; Zheng L; Liu T; Tian B; Xiao S; Huang J
    Front Oncol; 2023; 13():1166796. PubMed ID: 37621691
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer.
    Song JH; Oh TJ; An S; Lee KH; Kim JY; Kim JS
    World J Gastrointest Surg; 2023 Sep; 15(9):2032-2041. PubMed ID: 37901726
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.
    Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T
    Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes.
    Amitay EL; Carr PR; Jansen L; Walter V; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    J Natl Cancer Inst; 2019 May; 111(5):475-483. PubMed ID: 30388256
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran.
    Yari A; Samoudi A; Afzali A; Karam ZM; Karimaldini NK; Abadi MFS; Ziasistani M; Zangouey MR; Dabiri S
    J Gastrointest Cancer; 2021 Jun; 52(2):557-568. PubMed ID: 32495109
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The prognostic value of KRAS and BRAF in stage I-III colorectal cancer. A systematic review.
    Gallo G; Sena G; Vescio G; Papandrea M; Sacco R; Trompetto M; Sammarco G
    Ann Ital Chir; 2019; 90():127-137. PubMed ID: 30739887
    [TBL] [Abstract][Full Text] [Related]  

  • 77. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
    Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
    Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hypermethylated Promoters of Secreted Frizzled-Related Protein Genes are Associated with Colorectal Cancer.
    Hu H; Wang T; Pan R; Yang Y; Li B; Zhou C; Zhao J; Huang Y; Duan S
    Pathol Oncol Res; 2019 Apr; 25(2):567-575. PubMed ID: 30368728
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quantitative detection of SRY-Box 21 (
    Moradi K; Babaei E; Hosseinpour Feizi MA; Safaralizadeh R; Rezvani N
    Indian J Cancer; 2021; 58(2):217-224. PubMed ID: 33402569
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Novel DNA methylation biomarkers in stool and blood for early detection of colorectal cancer and precancerous lesions.
    Shen Y; Wang D; Yuan T; Fang H; Zhu C; Qin J; Xu X; Zhang C; Liu J; Zhang Y; Wen Z; Tang J; Wang Z
    Clin Epigenetics; 2023 Feb; 15(1):26. PubMed ID: 36803423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.